During the past decade, Optimus Medical Group conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 14 clinical trials were completed, i.e. on average, 73.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Optimus Medical Group" #1 sponsor was "Pfizer" with 6 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

According to Clinical.Site data, the most researched conditions in "Optimus Medical Group" are "Migraine" (4 trials), "Migraine, With or Without Aura" (3 trials), "COVID-19" (2 trials), "Episodic Migraine" (2 trials) and "HIV-1 Infection" (2 trials). Many other conditions were trialed in "Optimus Medical Group" in a lesser frequency.

Most popular intervention types in "Optimus Medical Group" are "Drug" (18 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Rimegepant" (4 trials), "Atogepant" (2 trials), "FTC/RPV/TAF" (2 trials) and "FTC/RPV/TAF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Optimus Medical Group" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Optimus Medical Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Optimus Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Optimus Medical Group, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".